What is the recommended dose for cotrimoxazole (sulfamethoxazole/trimethoprim)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage for Cotrimoxazole (Sulfamethoxazole/Trimethoprim)

The standard adult dosage for cotrimoxazole is one double-strength tablet (800 mg sulfamethoxazole/160 mg trimethoprim) twice daily for most infections, with dosage adjustments required based on indication, age, weight, and renal function. 1, 2

Adult Dosing by Indication

  • Urinary Tract Infections: One double-strength tablet (800 mg/160 mg) or two single-strength tablets (400 mg/80 mg) every 12 hours for 10-14 days 1
  • Acute Exacerbations of Chronic Bronchitis: One double-strength tablet or two single-strength tablets every 12 hours for 14 days 1
  • Traveler's Diarrhea: One double-strength tablet or two single-strength tablets every 12 hours for 5 days 1
  • Shigellosis: Same as UTI dosing but for 5 days duration 1

Pneumocystis jirovecii Pneumonia (PJP)

Treatment

  • Adults and Children: 75-100 mg/kg/day sulfamethoxazole and 15-20 mg/kg/day trimethoprim, divided into equal doses every 6 hours for 14-21 days 1, 2

Prophylaxis

  • Adults: One double-strength tablet daily 1, 2
  • Alternative Adult Regimen: One double-strength tablet three times weekly (typically Monday-Wednesday-Friday) 3
  • Children: 750 mg/m²/day sulfamethoxazole with 150 mg/m²/day trimethoprim given in divided doses twice daily, on 3 consecutive days per week 1, 2

Pediatric Dosing

  • Children ≥2 months: 40 mg/kg/day sulfamethoxazole and 8 mg/kg/day trimethoprim, divided into two doses every 12 hours 1, 2
  • Weight-based dosing guide:
    • 10 kg: 1 tablet (400 mg/80 mg) every 12 hours
    • 30 kg: 1½ tablets every 12 hours
    • 40 kg: 2 tablets or 1 double-strength tablet every 12 hours 1, 2
  • Not recommended for infants <2 months of age 1, 2

Renal Dosage Adjustments

  • Creatinine clearance >30 mL/min: Standard dosing regimen 1, 2
  • Creatinine clearance 15-30 mL/min: Half the usual regimen 1, 2
  • Creatinine clearance <15 mL/min: Use not recommended 1, 2

Important Clinical Considerations

  • Higher doses of trimethoprim (250 mg twice daily) may be more effective than standard doses for complicated UTIs, though co-trimoxazole still appears to have better efficacy in these cases 4
  • Single-day or single-dose treatment regimens have shown comparable cure rates to 7-day regimens for uncomplicated UTIs in women (82-87% cure rates) 5
  • Elderly patients may require dose adjustment as they demonstrate higher peak concentrations and larger area under the curve for trimethoprim, with reduced renal clearance compared to younger adults 6
  • Patient compliance is significantly better with once-daily regimens compared to twice-daily dosing (97.5% vs 79.1% compliance) 7
  • When used for PJP prophylaxis in HIV patients, treatment should be initiated when CD4+ T-cell counts fall below 200 cells/μL 3

Drug Interactions

  • Potential interaction between methotrexate and cotrimoxazole when dosed at 800 mg/160 mg twice daily; the prophylactic dose is generally better tolerated when used with methotrexate 8
  • Dosage adjustments may be needed when co-administered with certain antiretrovirals 8

Remember that cotrimoxazole is relatively nontoxic in patients without AIDS but requires careful monitoring for adverse effects including rash, pruritus, cytopenias, and transaminase elevations 3, 9.

References

Guideline

PJP Prophylaxis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Single day or single dose treatment of urinary tract infection with Co-trimoxazole.

Australian and New Zealand journal of medicine, 1980

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Trimethoprim-sulfamethoxazole.

Mayo Clinic proceedings, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.